| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| MIR210 |
|
microRNA 210
|
|
|
0.460 |
0.846 |
| MIR143 |
|
microRNA 143
|
|
|
0.462 |
0.885 |
| MIR31 |
|
microRNA 31
|
|
|
0.471 |
0.769 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| LINC02605 |
|
long intergenic non-protein coding RNA 2605
|
|
|
0.490 |
0.769 |
| MIR200A |
|
microRNA 200a
|
|
|
0.519 |
0.808 |
| KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
| H3P28 |
|
H3 histone pseudogene 28
|
|
|
0.553 |
0.692 |
| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| H3P13 |
|
H3 histone pseudogene 13
|
|
|
0.584 |
0.769 |
| IVL |
P07476
|
involucrin
|
|
|
0.626 |
0.500 |
| TAS2R13 |
Q9NYV9
|
taste 2 receptor member 13
|
G-protein coupled receptor
|
|
0.653 |
0.615 |
| SUMO4 |
Q6EEV6
|
small ubiquitin like modifier 4
|
|
|
0.653 |
0.577 |
| LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
| KIR2DS5 |
Q14953
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5
|
Receptor
|
|
0.678 |
0.500 |
| KIR2DL5B |
Q8NHK3
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5B
|
|
|
0.682 |
0.423 |
| KIR2DL5A |
Q8N109
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A
|
Receptor
|
|
0.711 |
0.423 |
| TH2LCRR |
|
T helper type 2 locus control region associated RNA
|
|
|
0.751 |
0.385 |
| PSORS1C3 |
|
psoriasis susceptibility 1 candidate 3
|
|
|
0.769 |
0.269 |
| LINC01185 |
|
long intergenic non-protein coding RNA 1185
|
|
|
0.743 |
0.346 |
| TRAF3IP2-AS1 |
|
TRAF3IP2 antisense RNA 1
|
|
|
0.792 |
0.154 |
| PSORS4 |
|
psoriasis susceptibility 4
|
|
|
0.861 |
0.077 |
| LYNX1-SLURP2 |
P0DP58
|
LYNX1-SLURP2 readthrough
|
|
|
0.839 |
0.115 |